NBIX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 4.60%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $74,342,552.46

Neurocrine Biosciences Insider Trading History Chart

Neurocrine Biosciences Share Price & Price History

^$145.35

▼ -0.75 (-0.51%)

As of 11/2/2026 04:00 PM ET

Days: 30 | 90 | 365

Neurocrine Biosciences Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
9/14/2026	David W. Boyer	Insider	Sell	826	$157.45	$130,053.70	8,722
9/14/2026	Matt Abernethy	CFO	Sell	2,311	$157.20	$363,289.20	42,808
7/28/2026	Leslie V Norwalk	Director	Sell	1,250	$182.01	$227,512.50	1,588
7/10/2026	Ingrid Delaet	Insider	Sell	4,367	$181.02	$790,514.34	16,225
7/9/2026	Darin Lippoldt	Insider	Sell	10,000	$179.60	$1,796,000.00	54,729
7/9/2026	Ingrid Delaet	Insider	Sell	8,433	$178.72	$1,507,145.76	16,225
7/8/2026	Ingrid Delaet	Insider	Sell	2,737	$178.54	$488,663.98	16,225
7/7/2026	Ingrid Delaet	Insider	Sell	3,401	$178.57	$607,316.57	16,225
6/29/2026	Darin Lippoldt	Insider	Sell	9,800	$170.16	$1,667,568.00	54,729
6/26/2026	Darin Lippoldt	Insider	Sell	200	$169.56	$33,912.00	54,729
6/5/2026	Stephen A. Sherwin	Director	Sell	25,000	$165.32	$4,133,000.00	15,860
6/4/2026	Leslie V Norwalk	Director	Sell	1,250	$168.06	$210,075.00	2,838
6/2/2026	Julie Cooke	Insider	Sell	36,937	$156.22	$5,770,298.14	22,374
6/1/2026	Jude Onyia	Insider	Sell	11,000	$160.25	$1,762,750.00	25,846
5/29/2026	Ingrid Delaet	Insider	Sell	2,261	$156.71	$354,321.31	16,225
5/27/2026	Jude Onyia	Insider	Sell	11,000	$155.53	$1,710,830.00	25,846
5/26/2026	David W. Boyer	Insider	Sell	3,888	$156.64	$609,016.32	7,799
5/19/2026	Kevin Charles Gorman	Director	Sell	245,088	$154.33	$37,824,431.04	511,293
5/15/2026	Richard F. Pops	Director	Sell	15,000	$157.65	$2,364,750.00	34,480
5/12/2026	Leslie V Norwalk	Director	Sell	3,810	$155.01	$590,588.10	2,429
1/16/2026	Kyle Gano	CEO	Sell	36,400	$132.70	$4,830,280.00	140,407
12/16/2025	Leslie V Norwalk	Director	Sell	1,190	$155.09	$184,557.10	6,239
12/15/2025	Leslie V Norwalk	Director	Sell	5,000	$152.23	$761,150.00	7,429
12/8/2025	Darin Lippoldt	Insider	Sell	4,376	$159.65	$698,628.40	43,405
11/25/2025	George J Morrow	Director	Sell	15,000	$143.37	$2,150,550.00	7,068
11/5/2025	William H. Rastetter	Director	Sell	18,000	$151.82	$2,732,760.00	40,360
11/4/2025	Kyle Gano	CEO	Sell	300	$141.97	$42,591.00	140,407
8/7/2025	Kevin Charles Gorman	Director	Sell	106,322	$126.41	$13,440,164.02	514,596
7/10/2025	Ingrid Delaet	Insider	Sell	457	$135.00	$61,695.00	4,730
7/9/2025	Jude Onyia	Insider	Sell	59,819	$130.46	$7,803,986.74	18,289
7/2/2025	Jude Onyia	Insider	Sell	20,362	$130.13	$2,649,707.06	18,289
5/27/2025	Kevin Charles Gorman	Director	Sell	9,613	$120.38	$1,157,212.94	514,596
5/5/2025	William H. Rastetter	Director	Sell	30,000	$110.20	$3,306,000.00	37,491
2/13/2025	Julie Cooke	Insider	Sell	1,551	$116.78	$181,125.78	19,544
2/13/2025	Kevin Charles Gorman	Director	Sell	5,844	$116.69	$681,936.36	521,618
2/13/2025	Matt Abernethy	CFO	Sell	2,558	$116.86	$298,927.88	34,775
2/10/2025	Julie Cooke	Insider	Sell	700	$118.28	$82,796.00	18,831
2/10/2025	Kevin Charles Gorman	Director	Sell	2,274	$118.37	$269,173.38	519,074
2/10/2025	Kyle Gano	CEO	Sell	980	$118.39	$116,022.20	137,658
2/3/2025	Ingrid Delaet	Insider	Sell	623	$149.29	$93,007.67	3,442
1/31/2025	Julie Cooke	Insider	Sell	1,740	$152.89	$266,028.60	18,202
1/31/2025	Kevin Charles Gorman	Director	Sell	2,707	$152.92	$413,954.44	517,030
1/31/2025	Kyle Gano	CEO	Sell	1,541	$152.87	$235,572.67	136,778
1/31/2025	Matt Abernethy	CFO	Sell	1,283	$152.87	$196,132.21	32,681
1/27/2025	Kevin Charles Gorman	Director	Sell	146,105	$149.46	$21,836,853.30	514,596
1/15/2025	Kyle Gano	CEO	Sell	65,000	$141.50	$9,197,500.00	135,392
12/31/2024	Ingrid Delaet	Insider	Sell	272	$138.10	$37,563.20	2,507
12/17/2024	Ingrid Delaet	Insider	Sell	1,091	$135.00	$147,285.00	2,507
11/29/2024	Jude Onyia	Insider	Sell	2,331	$126.29	$294,381.99	15,449
8/15/2024	William H. Rastetter	Director	Sell	14,250	$146.69	$2,090,332.50	37,491
8/13/2024	Gary A. Lyons	Director	Sell	11,570	$150.43	$1,740,475.10	119,047
8/13/2024	Ingrid Delaet	Insider	Sell	7,143	$150.10	$1,072,164.30	2,507
8/13/2024	Matt Abernethy	CFO	Sell	14,100	$150.38	$2,120,358.00	31,528
8/6/2024	Ingrid Delaet	Insider	Sell	273	$147.70	$40,322.10	6,607
8/1/2024	Julie Cooke	Insider	Sell	12,632	$153.26	$1,935,980.32	18,202
7/16/2024	Gary A. Lyons	Director	Sell	930	$150.03	$139,527.90	119,047
7/16/2024	Julie Cooke	Insider	Sell	900	$150.04	$135,036.00	18,202
7/1/2024	Julie Cooke	Insider	Sell	10,000	$140.19	$1,401,900.00	18,202
5/29/2024	Stephen A. Sherwin	Director	Sell	40,000	$133.46	$5,338,400.00	26,504
5/17/2024	Shalini Sharp	Director	Sell	1,106	$141.90	$156,941.40	994
5/15/2024	Matt Abernethy	CFO	Sell	15,000	$140.24	$2,103,600.00	31,528
5/14/2024	Gary A. Lyons	Director	Sell	12,500	$135.63	$1,695,375.00	116,947
5/6/2024	Ingrid Delaet	Insider	Sell	273	$140.55	$38,370.15	7,507
4/15/2024	Eric Benevich	Insider	Sell	19,818	$133.36	$2,642,928.48	40,778
3/21/2024	Ingrid Delaet	Insider	Sell	5,000	$145.06	$725,300.00	7,507
3/14/2024	Eric Benevich	Insider	Sell	75,000	$139.38	$10,453,500.00	40,778
3/14/2024	George J. Morrow	Director	Sell	40,000	$139.42	$5,576,800.00
3/11/2024	Ingrid Delaet	Insider	Sell	200	$140.00	$28,000.00	7,507
3/11/2024	Richard F. Pops	Director	Sell	100	$140.00	$14,000.00	29,512
3/8/2024	Ingrid Delaet	Insider	Sell	1,800	$140.03	$252,054.00	7,507
3/8/2024	Richard F. Pops	Director	Sell	1,700	$140.05	$238,085.00	29,512
2/29/2024	Ingrid Delaet	Insider	Sell	273	$135.51	$36,994.23	7,507
2/27/2024	Leslie V. Norwalk	Director	Sell	8,000	$135.67	$1,085,360.00
2/20/2024	Richard F. Pops	Director	Sell	15,000	$132.47	$1,987,050.00	29,512
2/13/2024	Eiry Roberts	Insider	Sell	1,114	$132.96	$148,117.44	23,716
2/13/2024	Kevin Charles Gorman	CEO	Sell	2,832	$133.02	$376,712.64	514,596
2/13/2024	Matt Abernethy	CFO	Sell	1,352	$132.85	$179,613.20	31,528
2/8/2024	David W. Boyer	Insider	Sell	1,328	$135.41	$179,824.48	4,895
2/8/2024	Kevin Charles Gorman	CEO	Sell	2,274	$134.15	$305,057.10	506,962
2/8/2024	Matt Abernethy	CFO	Sell	980	$134.21	$131,525.80	30,314
2/6/2024	David W. Boyer	Insider	Sell	456	$141.96	$64,733.76	4,894
2/6/2024	Kevin Charles Gorman	CEO	Sell	3,040	$142.18	$432,227.20	504,919
2/6/2024	Matt Abernethy	CFO	Sell	1,280	$142.19	$182,003.20	29,434
1/31/2024	Eiry Roberts	Insider	Sell	1,457	$140.79	$205,131.03	20,832
1/31/2024	Kevin Charles Gorman	CEO	Sell	2,707	$140.69	$380,847.83	502,188
1/31/2024	Matt Abernethy	CFO	Sell	1,283	$140.72	$180,543.76	28,284
1/22/2024	Darin Lippoldt	Insider	Sell	10,000	$139.86	$1,398,600.00	35,882
1/8/2024	Kevin Charles Gorman	CEO	Sell	105,835	$132.44	$14,016,787.40	499,754
1/2/2024	Kyle Gano	Insider	Sell	75,000	$131.47	$9,860,250.00	130,250
1/2/2024	William H. Rastetter	Director	Sell	11,044	$131.47	$1,451,954.68	51,741
12/22/2023	Eiry Roberts	Insider	Sell	10,000	$126.74	$1,267,400.00	19,521
12/12/2023	Eiry Roberts	Insider	Sell	13,925	$120.30	$1,675,177.50	29,521
12/8/2023	Eiry Roberts	Insider	Sell	300	$120.10	$36,030.00	29,521
12/6/2023	Darin Lippoldt	Insider	Sell	20,830	$119.86	$2,496,683.80	35,882
12/1/2023	Gary A. Lyons	Director	Sell	5,000	$116.77	$583,850.00	203,697
11/29/2023	Jude Onyia	Insider	Sell	2,331	$113.57	$264,731.67	11,732
11/27/2023	Darin Lippoldt	Insider	Sell	10,919	$112.27	$1,225,876.13	35,882

SEC Filings (Institutional Ownership Changes) for Neurocrine Biosciences (NASDAQ:NBIX)

92.59% of Neurocrine Biosciences stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Neurocrine Biosciences Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/2/2026	REAP Financial Group LLC	344	$49K	0.0%	N/A	0.000%
11/2/2026	Capstone Wealth Management LLC	1,825	$0.26M	0.1%	-14.5%	0.002%
11/2/2026	Collaborative Fund Advisors LLC	2,165	$0.31M	0.2%	-67.3%	0.002%
10/31/2026	Chicago Partners Investment Group LLC	6,293	$0.90M	0.0%	-25.7%	0.006%
10/31/2026	Covestor Ltd	668	$95K	0.1%	-10.7%	0.001%
10/30/2026	Provenance Wealth Advisors LLC	2,902	$0.41M	0.0%	N/A	0.003%
10/30/2026	Oregon Public Employees Retirement Fund	21,084	$2.99M	0.0%	+1.4%	0.021%
10/30/2026	Factory Mutual Insurance Co.	4,582	$0.65M	0.0%	N/A	0.005%
10/29/2026	Bank Julius Baer & Co. Ltd Zurich	24,125	$3.42M	0.0%	+1.5%	0.024%
10/29/2026	Sumitomo Mitsui Trust Group Inc.	211,026	$29.93M	0.0%	-2.1%	0.208%
10/29/2026	Mirae Asset Global Investments Co. Ltd.	12,928	$1.83M	0.0%	N/A	0.013%
10/29/2026	Profund Advisors LLC	16,173	$2.29M	0.1%	+52.1%	0.016%
10/29/2026	ProShare Advisors LLC	7,388	$1.05M	0.0%	+1.7%	0.007%
10/29/2026	Summit Global Investments	18,708	$2.65M	0.1%	-36.4%	0.018%
10/29/2026	State of Wyoming	2,116	$0.30M	0.0%	+129.0%	0.002%
10/28/2026	Raleigh Capital Management Inc.	225	$32K	0.0%	+561.8%	0.000%
10/28/2026	VIRGINIA RETIREMENT SYSTEMS ET Al	291,723	$41.38M	0.3%	+18.6%	0.287%
10/28/2026	Parcion Private Wealth LLC	2,980	$0.42M	0.0%	-11.6%	0.003%
10/28/2026	Soltis Investment Advisors LLC	1,747	$0.25M	0.0%	-5.3%	0.002%
10/28/2026	Choreo LLC	3,492	$0.50M	0.0%	-2.8%	0.003%
10/28/2026	China Universal Asset Management Co. Ltd.	18,547	$2.57M	0.1%	+15.9%	0.018%
10/28/2026	Motley Fool Asset Management LLC	3,067	$0.44M	0.0%	+20.7%	0.000%
10/28/2026	North Dakota State Investment Board	3,032	$0.43M	0.0%	+5.3%	0.000%
10/28/2026	VestGen Advisors LLC	2,197	$0.31M	0.0%	-7.2%	0.000%
10/27/2026	Smith Group Asset Management LLC	2,770	$0.39M	0.0%	-4.5%	0.003%
10/27/2026	Generali Asset Management SPA SGR	17,809	$2.53M	0.0%	+2.2%	0.018%
10/27/2026	Asset Management One Co. Ltd.	45,354	$6.43M	0.0%	+1.0%	0.045%
10/26/2026	Oppenheimer & Co. Inc.	53,588	$7.60M	0.1%	+12.1%	0.053%
10/26/2026	Park Avenue Securities LLC	8,737	$1.24M	0.0%	+1.6%	0.009%
10/23/2026	Signaturefd LLC	782	$0.11M	0.0%	+19.9%	0.001%
10/23/2026	Citizens Financial Group Inc. RI	3,255	$0.46M	0.0%	-23.4%	0.003%
10/23/2026	Sowell Financial Services LLC	5,342	$0.76M	0.0%	-11.8%	0.005%
10/23/2026	Gibbs Wealth Management	2,695	$0.38M	0.0%	+55.1%	0.003%
10/23/2026	Fifth Third Wealth Advisors LLC	3,920	$0.56M	0.0%	+14.8%	0.004%
10/23/2026	Sterling Capital Management LLC	589	$84K	0.0%	-83.6%	0.001%
10/23/2026	Inspire Investing LLC	8,530	$1.21M	0.1%	+12.7%	0.008%
10/22/2026	Yousif Capital Management LLC	27,548	$3.91M	0.0%	-4.9%	0.027%
10/22/2026	Brookstone Capital Management	4,809	$0.68M	0.0%	+2.7%	0.005%
10/22/2026	Root Financial Partners LLC	1,034	$0.15M	0.0%	-30.0%	0.001%
10/21/2026	Sowell Financial Services LLC	5,342	$0.76M	0.0%	-11.8%	0.005%
10/21/2026	Nisa Investment Advisors LLC	4,500	$0.64M	0.0%	+3.2%	0.004%
10/21/2026	Robeco Institutional Asset Management B.V.	116,809	$16.57M	0.0%	+8.2%	0.115%
10/21/2026	Diversify Advisory Services LLC	11,346	$1.55M	0.0%	+352.8%	0.011%
10/20/2026	Cordatus Wealth Management LLC	2,105	$0.30M	0.1%	N/A	0.002%
10/19/2026	BDF Gestion	10,523	$1.49M	0.2%	-11.3%	0.010%
10/19/2026	Generali Investments Management Co LLC	4,103	$0.58M	0.1%	-61.5%	0.004%
10/17/2026	IFP Advisors Inc	2,819	$0.40M	0.0%	-6.3%	0.003%
10/16/2026	Vontobel Holding Ltd.	3,109	$0.44M	0.0%	+8.8%	0.003%
10/16/2026	Shelton Wealth Management LLC	9,959	$1.41M	0.5%	+62.9%	0.010%
10/16/2026	Paragon Capital Management Inc.	9,648	$1.37M	1.0%	-0.9%	0.009%
10/16/2026	Ellsworth Advisors LLC	2,040	$0.29M	0.0%	-94.9%	0.002%
10/15/2026	Assenagon Asset Management S.A.	145,818	$20.68M	0.0%	-34.5%	0.143%
10/15/2026	Brindle & Bay Financial Advisors LLC	1,431	$0.20M	0.1%	+12.6%	0.001%
10/15/2026	Ninety One UK Ltd	434,881	$61.68M	0.1%	+160,372.7%	0.428%
10/15/2026	State of Alaska Department of Revenue	9,629	$1.37M	0.0%	-2.3%	0.009%
10/15/2026	Curated Wealth Partners LLC	3,021	$0.43M	0.0%	-93.7%	0.003%
10/15/2026	Winnacle Wealth LLC	5,230	$0.74M	0.5%	-9.2%	0.005%
10/14/2026	Signal Advisors Wealth LLC	1,526	$0.22M	0.0%	N/A	0.002%
10/14/2026	Krilogy Financial LLC	5,467	$0.77M	0.0%	-20.6%	0.005%
10/13/2026	NorthCrest Asset Manangement LLC	7,417	$1.05M	0.0%	-9.3%	0.007%
10/13/2026	Avior Wealth Management LLC	2,554	$0.36M	0.0%	-14.3%	0.003%
10/13/2026	Perpetual Ltd	2,638	$0.37M	0.0%	-7.3%	0.003%
10/9/2026	GK Wealth Management LLC	427	$61K	0.0%	N/A	0.000%
10/9/2026	Wedmont Private Capital	1,936	$0.27M	0.0%	+15.5%	0.002%
10/9/2026	GAMMA Investing LLC	3,858	$0.55M	0.0%	+3.9%	0.004%
10/8/2026	Farther Finance Advisors LLC	3,438	$0.49M	0.0%	+37.4%	0.003%
10/8/2026	CoreCap Advisors LLC	565	$80K	0.0%	+782.8%	0.001%
10/8/2026	Whalen Wealth Management Inc.	3,706	$0.53M	0.2%	-39.9%	0.004%
10/8/2026	City Center Advisors LLC	2,010	$0.29M	0.2%	-10.5%	0.002%
10/6/2026	Congress Asset Management Co.	120,842	$17.14M	0.1%	+46.5%	0.119%
10/6/2026	Moody National Bank Trust Division	6,156	$0.87M	0.1%	N/A	0.006%
10/5/2026	Argent Capital Management LLC	17,360	$2.46M	0.0%	-5.4%	0.017%
10/2/2026	Private Client Services LLC	2,629	$0.37M	0.1%	-16.7%	0.003%
9/23/2026	QRG Capital Management Inc.	18,903	$3.19M	0.0%	+14.4%	0.019%
9/23/2026	Envestnet Portfolio Solutions Inc.	2,942	$0.50M	0.0%	+25.1%	0.003%
9/22/2026	Andra AP fonden	63,191	$10.65M	0.1%	-57.4%	0.062%
9/11/2026	Talon Private Wealth LLC	4,662	$0.79M	0.1%	-2.7%	0.005%
9/9/2026	Sequoia Financial Advisors LLC	6,351	$1.07M	0.0%	+31.0%	0.006%
9/9/2026	Tidal Investments LLC	81,460	$13.73M	0.0%	+186.7%	0.080%
9/9/2026	National Pension Service	16,310	$2.75M	0.0%	-48.0%	0.016%
9/9/2026	WINTON GROUP Ltd	1,600	$0.27M	0.0%	N/A	0.002%
9/9/2026	Engineers Gate Manager LP	18,361	$3.09M	0.0%	+64.0%	0.018%
9/9/2026	Integrated Wealth Concepts LLC	8,041	$1.36M	0.0%	-41.5%	0.008%
9/9/2026	RFG Advisory LLC	8,195	$1.38M	0.0%	N/A	0.008%
9/9/2026	NewEdge Advisors LLC	12,619	$2.13M	0.0%	-3.4%	0.012%
9/9/2026	IFP Advisors Inc	3,008	$0.51M	0.0%	+7.7%	0.003%
9/9/2026	Squarepoint Ops LLC	44,143	$7.44M	0.0%	-91.0%	0.043%
9/9/2026	Baird Financial Group Inc.	39,868	$6.72M	0.0%	+3.3%	0.039%
9/8/2026	Allworth Financial LP	14,853	$2.50M	0.0%	+74.6%	0.015%
9/8/2026	Arizona State Retirement System	27,337	$4.61M	0.0%	+0.9%	0.027%
9/8/2026	West Family Investments Inc.	1,923	$0.32M	0.1%	N/A	0.002%
9/8/2026	Carmignac Gestion	214,100	$36.08M	0.5%	+15.1%	0.211%
9/8/2026	Nykredit A S	30,811	$5.19M	0.0%	N/A	0.030%
9/2/2026	Range Advisory LLC	2,237	$0.38M	0.0%	N/A	0.002%
8/27/2026	Corient Private Wealth LP	54,680	$9.22M	0.0%	+21.4%	0.054%
8/26/2026	Amundi	220,463	$37.16M	0.0%	+8.3%	0.217%
8/26/2026	HighTower Advisors LLC	8,205	$1.38M	0.0%	-26.7%	0.008%
8/25/2026	VIRGINIA RETIREMENT SYSTEMS ET Al	245,923	$41.45M	0.2%	N/A	0.242%
8/23/2026	Nilsine Partners LLC	10,013	$1.69M	0.1%	+3.6%	0.010%
8/23/2026	Saudi Central Bank	6,674	$1.13M	0.0%	+81.4%	0.007%

Data available starting January 2016

Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, neuroendocrine, and neuropsychiatric disorders in the United States and internationally. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids. Its product candidates in clinical development include valbenazine to treat dyskinetic cerebral palsy in pediatrics and adults; NBI-921352 to treat developmental and epileptic encephalopathy syndrome in pediatrics and adults; NBI-827104 to treat epileptic encephalopathy with continuous spike-and-wave during sleep; NBI-1076986 to treat movement disorders; crinecerfront to treat congenital adrenal hyperplasia in adults and children; EFMODY to treat congenital adrenal hyperplasia and adrenal insufficiency in adults; valbenazine for the adjunctive treatment of schizophrenia; NBI-1065845 for the treatment of inadequate response to treatment in major depressive disorder; luvadaxistat to treat cognitive impairment related to schizophrenia; NBI-1117568 for the treatment of schizophrenia; NBI-1070770 to treat major depressive disorder; NBI-1117570 for the treatment of symptoms of psychosis and cognition in neurological and neuropsychiatric conditions; and NBI-1117569, NBI-1117567, and NBI-1065890 to treat CNS indications. The company also has license and collaboration agreements with Heptares Therapeutics Limited; Takeda Pharmaceutical Company Limited; Idorsia Pharmaceuticals Ltd; Xenon Pharmaceuticals Inc.; Voyager Therapeutics, Inc.; BIAL Portela & Ca, S.A.; Mitsubishi Tanabe Pharma Corporation; and AbbVie Inc. The company was incorporated in 1992 and is headquartered in San Diego, California.

Today's Range

Now: $145.35

$143.75

$147.57

50 Day Range

MA: $146.49

$135.13

$158.35

52 Week Range

Now: $145.35

$122.14

$186.12

Volume

2,007,611 shs

Average Volume

1,296,500 shs

Market Capitalization

$14.77 billion

P/E Ratio

20.10

Dividend Yield

N/A

Beta

0.4

Who are the company insiders with the largest holdings of Neurocrine Biosciences?: Neurocrine Biosciences' top insider shareholders include:
Neurocrine Biosciences Inc (Major Shareholder)
Kevin Charles Gorman (CEO)
Kevin Charles Gorman (Director)
Gary A Lyons (Director)
Gary A Lyons (Director)
Haig P Bozigian (Insider)
Darin Lippoldt (Insider)
Dimitri E Grigoriadis (Insider)
Kyle Gano (CEO)
Timothy P Coughlin (CFO)
Learn More about top insider investors at Neurocrine Biosciences.
Who are the major institutional investors of Neurocrine Biosciences?: Neurocrine Biosciences' top institutional investors include:
Ninety One UK Ltd — 0.43%
VIRGINIA RETIREMENT SYSTEMS ET Al — 0.29%
Sumitomo Mitsui Trust Group Inc. — 0.21%
Assenagon Asset Management S.A. — 0.14%
Congress Asset Management Co. — 0.12%
Robeco Institutional Asset Management B.V. — 0.11%
Learn More about top institutional investors of Neurocrine Biosciences stock.
Which institutional investors are selling Neurocrine Biosciences stock?: During the previous quarter, NBIX stock was sold by these institutional investors:
Assenagon Asset Management S.A.
Curated Wealth Partners LLC
Ellsworth Advisors LLC
Summit Global Investments
Generali Investments Management Co LLC
Sumitomo Mitsui Trust Group Inc.
Collaborative Fund Advisors LLC
Sterling Capital Management LLC
During the previous year, company insiders that have sold Neurocrine Biosciences company stock include:
Kevin Charles Gorman (Director)
Kyle Gano (CEO)
Darin Lippoldt (Insider)
Matt Abernethy (CFO)
William H Rastetter (Director)
Richard F Pops (Director)
Jude Onyia (Insider)
Julie Cooke (Insider)
Ingrid Delaet (Insider)
Stephen A Sherwin (Director)
David W Boyer (Insider)
Leslie V Norwalk (Director)
George J Morrow (Director)
Learn More investors selling Neurocrine Biosciences stock.
Which institutional investors are buying Neurocrine Biosciences stock?: Within the previous quarter, NBIX stock was bought by institutional investors including:
Ninety One UK Ltd
VIRGINIA RETIREMENT SYSTEMS ET Al
Congress Asset Management Co.
Mirae Asset Global Investments Co. Ltd.
Diversify Advisory Services LLC
Robeco Institutional Asset Management B.V.
Moody National Bank Trust Division
Oppenheimer & Co. Inc.